Prof John D. Potter*
This blog briefly surveys the emerging scientific evidence on the longer-term burden of symptoms and disease in survivors of the COVID-19 pandemic. Many of these symptoms point to damage in the brain and heart. These long-term harms add to the wide range of other reasons for Aotearoa/New Zealand to persist with its successful COVID-19 elimination strategy.
Prof Nick Wilson, Dr Amanda Kvalsvig, Prof Michael Baker
In this blog we comment on the current COVID-19 situation globally and in NZ. We focus on potential revisions to NZ’s Alert Level system that involve improved use of mass masking, targeted internal travel restrictions, and gathering/event limits. These interventions could all help accelerate rapid progress back to elimination status for NZ while minimising disruption of economic activity and education.
A bit like a letter home. I have now been full-time at the University of Melbourne since 2019. Before that, I was 20 years at the University of Otago, Wellington. Indeed, I set up this very Public Health Expert Blog with Nick Wilson ten years ago. Now I am your Australian correspondent.
Dr Jaijus Pallippadan-Johny1, Dr John McDermott2, Rodney Jones1 and Michael Duddin1 (1 Wigram Capital Advisors, Auckland; 2Motu Economic and Policy Research, Wellington)
In this blog, we introduce our modelling approach to estimating the transmissibility of the SARS-CoV-2 virus, the cause of the COVID-19 pandemic. We demonstrate the usefulness of the Wallinga model for the calculation of the effective reproduction number and show the major impact of the lockdown on containing the pandemic in New Zealand.
Prof Nick Wilson, Dr Sophie Febery, Dr Ling Chan, Dr Amanda Kvalsvig, Prof Michael Baker
In this blog we identify six likely benefits from requiring fabric mask use in public transportation and border control settings in the “peri-elimination” context that New Zealand is currently in. Given these likely benefits and the relatively low costs (especially if the Government provides free masks as per Hong Kong), such a policy should be given very serious consideration by health authorities in the transition to level 2.